Body Shape

Human body shape is a highly variable and complex trait, reflecting an individual’s unique physical characteristics. It is broadly defined by the distribution of fat, muscle, and bone, and is often assessed through various anthropometric measurements^[1]. Common indicators include body mass index (BMI), waist circumference (WC), hip circumference, height, and specific measures of fat distribution, such as subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) ^[1]. These traits are dynamic, changing throughout an individual’s lifespan due to a combination of genetic predispositions and environmental influences.

The biological basis of body shape is multifactorial, involving a significant genetic component alongside lifestyle factors like diet and physical activity. Genetic studies, often utilizing high-density SNP arrays, have identified numerous genetic variants associated with different aspects of body shape^[1]. For instance, specific single nucleotide polymorphisms (SNPs) have been linked to mean BMI and mean WC, with notable associations found in genes such as SSTR2, IL6R, AGTR1, and FSHR ^[1]. Research has also identified SNPs on chromosomes like 16 and 2p16 that show strong associations with BMI and hip circumference ^[1]. The comprehensive mapping of human genetic variation, such as the HapMap project, has been instrumental in these large-scale association studies ^[2], often employing statistical methods like genomic control to account for population structure ^[3].

Body shape has considerable clinical relevance, as specific patterns of fat distribution are closely linked to various health outcomes. For example, excess visceral fat is associated with an increased risk for metabolic disorders and cardiovascular disease^[4]. Understanding the genetic underpinnings of body shape can aid in identifying individuals at higher risk for these conditions, potentially allowing for earlier interventions and personalized health strategies. Regular monitoring of body shape indicators, such as BMI and waist circumference, is a standard practice in clinical settings to assess overall health risk.

Beyond its biological and clinical implications, body shape holds significant social importance. Societal perceptions, cultural ideals, and individual self-image are often influenced by body shape. Public health initiatives frequently use body shape metrics to address population-level health challenges like obesity. Research into the genetic and environmental factors influencing body shape contributes to a broader understanding of human diversity and can help inform public health campaigns, promote healthier lifestyles, and challenge stigmatizing views related to body size and form.

Limitations

Scope of Genetic Variation Coverage

Current genome-wide association studies (GWAS) often utilize a subset of all known single nucleotide polymorphisms (SNPs) from resources like the HapMap, which means they may not capture every genetic variant influencing body shape^[2]. This limited coverage can lead to missing associations with certain genes or regulatory regions, thus impacting a comprehensive understanding of the genetic architecture underlying body shape. Consequently, this can contribute to the ‘missing heritability’ phenomenon, where identified genetic variants explain only a fraction of the observed phenotypic variation, leaving significant knowledge gaps in the genetic underpinnings of body shape.

Generalizability and Population Structure

Genetic studies of body shape must carefully account for population structure, as differences in ancestral backgrounds can confound associations between genetic markers and traits. While advanced statistical methods, such as principal components analysis, are employed to correct for population substructure, and genomic inflation factors are assessed to indicate residual stratification, these measures highlight the inherent challenges in ensuring findings are broadly applicable across diverse populations^[5]. The necessity of these rigorous controls underscores that genetic influences on body shape can vary between populations, limiting the direct generalizability of results from one specific cohort to others with different ancestral origins.

Phenotype Definition and Measurement Consistency

The definition and measurement of body shape phenotypes, such as body mass index (BMI) or waist circumference, can vary across studies, potentially affecting the consistency and comparability of results. Differences in how these traits are quantified, or which specific measures are prioritized, can lead to discrepancies when attempting to replicate findings or synthesize evidence from multiple studies^[6]Such variations in phenotyping can obscure true genetic associations or lead to conflicting reports, making it challenging to establish robust and universally applicable genetic markers for specific body shape characteristics.

Variants

Genetic variations play a crucial role in influencing individual differences in body shape and composition, including measures like body mass index (BMI) and waist circumference. These variations can affect genes involved in metabolism, appetite regulation, cellular stress responses, and developmental pathways. Understanding the impact of specific single nucleotide polymorphisms (SNPs) within or near these genes provides insight into the genetic architecture of adiposity-related traits.

The variant rs150717769 is located in a region that encompasses both the TRAP1 and DNASE1 genes. TRAP1 (TNF Receptor Associated Protein 1) encodes a mitochondrial chaperone protein essential for maintaining mitochondrial health, protecting cells from stress, and regulating cellular energy metabolism. Alterations in TRAP1function can impact cellular energy expenditure and fat storage, thereby influencing body composition.DNASE1 (Deoxyribonuclease I) is an enzyme responsible for digesting DNA, playing roles in apoptosis and the clearance of extracellular DNA. While its direct link to adiposity is less direct, variations impacting DNASE1 could subtly influence cellular turnover or inflammatory processes that contribute to metabolic health. Similarly, the rs17867127 variant is found within GRM8 (Glutamate Metabotropic Receptor 8), a gene encoding a receptor for the neurotransmitter glutamate, primarily active in the brain. GRM8 is involved in modulating synaptic transmission and has been implicated in appetite regulation and energy homeostasis. A variant affecting GRM8 activity could alter signals related to satiety and food intake, thereby impacting body weight and waist circumference.

Variants rs75156321 and rs111783937 are associated with FGF12 (Fibroblast Growth Factor 12), an intracellular protein predominantly expressed in neurons. Unlike other FGF family members, FGF12 functions within cells, contributing to neuronal development and the regulation of voltage-gated sodium channels. Given the brain’s central role in governing metabolism, appetite, and physical activity, variations in FGF12could influence these neural circuits, indirectly affecting energy balance and contributing to differences in body shape. Another important locus isMIR100HG (MIR100 Host Gene), which hosts several microRNAs, including miR-100, miR-125b, and let-7a. MicroRNAs are small non-coding RNAs that regulate gene expression and are known to be involved in fundamental biological processes such as cell proliferation, differentiation, and metabolism. The rs17126580 variant within MIR100HGmay influence the expression or processing of these microRNAs, potentially leading to dysregulation of metabolic pathways, insulin sensitivity, and adipogenesis, which collectively contribute to an individual’s BMI and waist circumference. Finally, thers7089940 variant is located in TLX1NB (TLX1 Neighboring Gene). While TLX1NB itself is less characterized, its proximity to TLX1(T-cell leukemia homeobox 1), a transcription factor involved in development, suggests it may play a role in gene regulation. Variations in this region could potentially affect nearby gene expression or other uncharacterized functions that indirectly impact metabolic processes or tissue development relevant to body shape.

Key Variants

RS ID	Gene	Related Traits
rs150717769	TRAP1, DNASE1	body shape measurement
rs17867127	GRM8	body shape measurement
rs75156321 rs111783937	FGF12	body shape measurement
rs17126580	MIR100HG	body shape measurement
rs7089940	TLX1NB	body shape measurement

Classification, Definition, and Terminology

Body shape measurement encompasses the quantification of various physical dimensions and the distribution of fat within the body. These measurements are important for understanding an individual’s health status and their risk for developing certain diseases, particularly those related to obesity.

Body Mass Index (BMI)

Body Mass Index is a commonly used clinical measure to assess overall body fatness. It is calculated as an individual’s weight in kilograms divided by the square of their height in meters. BMI is used to categorize individuals into different weight classifications:

• Overweight: Individuals are classified as overweight if their BMI is 25 kg/m² or greater.
• Obese:Individuals are considered obese if their BMI is 30 kg/m² or greater. Obesity is a significant health concern, contributing to morbidity and mortality by increasing the risk of type 2 diabetes mellitus, heart disease, metabolic syndrome, hypertension, stroke, and certain forms of cancer. Genetic factors are understood to play a role in an individual’s susceptibility to obesity in response to environmental factors.

Body Composition and Fat Distribution Measures

Beyond BMI, more specific measurements provide detailed insights into the distribution of body fat, especially around the abdomen, which is particularly relevant to health risks. These measures include:

• Waist Circumference (WC): This measurement quantifies abdominal adiposity. It is typically taken at the level of the umbilicus. Waist circumference can be analyzed for men and women combined or separately. Mean WC is often derived by averaging measurements taken across multiple examinations.
• Subcutaneous Fat (SAT): This refers to the layer of fat located directly beneath the skin. The volume of subcutaneous fat can be accurately assessed using computed tomography (CT).
• Visceral Fat (VAT): This type of fat is stored around the internal organs within the abdominal cavity. Like subcutaneous fat, its volume is determined through computed tomography (CT).
• Waist Circumference by Computed Tomography: This method uses CT imaging to provide a precise measurement of the waist, offering a detailed assessment of abdominal dimensions.
• Sagittal Diameter by Computed Tomography: Also known as sagittal abdominal diameter, this measurement is obtained from CT scans. It represents the anterior-posterior diameter of the abdomen and serves as another indicator of central fat accumulation.

These detailed body shape measurements offer a more comprehensive understanding of an individual’s fat distribution and its implications for health, complementing the broader assessment provided by BMI.

Body shape, characterized by measures such as Body Mass Index (BMI), waist circumference (WC), and the distribution of fat, is a complex trait influenced by both genetic and environmental factors^[7][8]. These measures reflect an individual’s adiposity and frame size ^[4].

At a biological level, body shape is determined by the accumulation and distribution of adipose tissue. Two primary types of adipose tissue discussed in relation to body shape include subcutaneous fat (SAT), located just under the skin, and visceral fat (VAT), which surrounds internal organs^[9]. The relative proportions and locations of these fat types contribute significantly to overall body shape and are assessed using methods like multi-detector computed tomography^[9].

Genetic factors play a substantial role in determining an individual’s body shape and susceptibility to adiposity^[10][8]. Research efforts have focused on identifying genes underlying normal variation in human adiposity, contributing to a growing understanding of the human obesity gene map^[10][11]. Genome-wide linkage analyses have identified chromosomal regions linked to traits like BMI ^[12] and WC ^[13]. For instance, chromosome 6 has been linked to waist circumference ^[13]. These genetic influences can also exhibit sex and age-specific effects, as observed in studies linking chromosomal regions to BMI ^[12].

Molecular and cellular investigations into body shape involve the study of single nucleotide polymorphisms (SNPs) through genome-wide association studies (GWAS)^[2][14]. These studies aim to discover genotypes underlying complex human phenotypes, building upon methods like positional cloning ^{[15][16][17][18]}. Understanding these genetic underpinnings is crucial, given the associations between overweight, obesity, and health outcomes such as mortality from cancer^[19].

Clinical Relevance

Body shape traits, particularly those related to fat distribution, are important indicators of health and disease risk. The prevalence of obesity has increased, influencing trends in conditions such as cardiovascular disease (CVD)^[20]. Understanding these traits provides insight into an individual’s predisposition to various health complications.

Waist circumference (WC) is a clinically relevant body shape trait, serving as a key indicator of abdominal adiposity. Research has linked waist circumference to specific chromosomal regions, such as chromosome 6q23^[13], suggesting a genetic influence on this trait. Elevated waist circumference and overall obesity are well-established risk factors for numerous health issues. Obesity significantly increases the risk of all-cause mortality^[19], vascular diseases ^[21], and non-vascular causes of death, including certain types of cancer^[19]. It is recognized as an independent risk factor for cardiovascular disease^[21], which remains a leading cause of morbidity and mortality^[20]. The increasing rates of obesity may slow the progress made in reducing CVD mortality^[20].

Beyond simple waist circumference, more precise assessments of body fat distribution offer additional clinical value. Traits like subcutaneous fat, visceral fat, and sagittal diameter, often assessed using computed tomography (CT), provide detailed information about where fat is stored in the body. Visceral fat, in particular, is frequently associated with metabolic dysfunction and increased disease risk. Analyzing these body shape traits helps to identify individuals at higher risk for conditions such as cardiovascular disease, even when accounting for general body mass, thereby aiding in early intervention and personalized health management.

Population Studies

Population studies play a crucial role in understanding the distribution, determinants, and health implications of various body shapes across diverse groups. These studies often involve large cohorts and epidemiological designs to collect anthropometric data and link it to health outcomes.

• The Caerphilly Study The Caerphilly study investigated body fatness and frame size specifically in men ^[22]. This research formed part of broader collaborative studies on heart disease^[23].

• British Women’s Heart and Health StudyThis study examined geographical variations in cardiovascular disease, its risk factors, and their management among older women^[4].

• Avon Longitudinal Study of Parents and Children (ALSPAC) In the ALSPAC cohort, anthropometric measurements were collected from children between 7 and 11 years of age ^[24]. At age 9, 7,470 children underwent whole-body dual-energy X-ray absorptiometry (DXA) to measure body composition^[24]. Research utilizing ALSPAC data has explored the links between size at birth and DXA-derived lean and fat mass at 9 to 10 years ^[25], as well as the impact of maternal smoking during pregnancy on offspring fat and lean mass in childhood ^[26].

• Exeter Family Study of Childhood Health (EFSOCH) EFSOCH is a prospective study that recruited parents and children from a consecutive birth cohort in Exeter, UK. Participants were of self-reported “white” European descent ^[27]. Parental height and weight were measured by research midwives, and maternal pre-pregnant weight was self-reported ^[27].

• FINRISK1997 This population-based survey, conducted in Finland, monitored changes in cardiovascular risk factors over time ^[28].

• The Atherosclerosis Risk in Communities (ARIC) StudyThe ARIC Study was designed to investigate the risk of atherosclerosis within various communities^[29].

• Old Order Amish Studies Studies among the Old Order Amish population have characterized diabetes and conducted heritability analyses ^[30]. Other research in this community has focused on the incidence of hip fracture^[31].

Frequently Asked Questions About Body Shape Measurement

These questions address the most important and specific aspects of body shape measurement based on current genetic research.

---

1. Why can’t I lose weight even when my friend eats more than me?

Your body shape and how you process food are significantly influenced by your genetics, even if you share similar lifestyles. Genetic variants can affect your metabolism and how your body stores fat. For instance, specific SNPs in genes likeSSTR2 or IL6R are linked to differences in BMI and waist circumference, meaning your body might respond differently to food intake than your friend’s.

2. My sibling is thin but I’m not - why the difference?

Even within the same family, individual genetic variations play a big role in body shape. While you share many genes, unique combinations and environmental factors differentiate how fat, muscle, and bone are distributed. This means that despite similar family backgrounds, your genetic predispositions can lead to distinct body compositions.

3. Does my family’s health history mean I’ll struggle with weight?

Yes, your family’s health history can indicate a genetic predisposition for certain body shapes and fat distribution patterns. If your family has a history of metabolic disorders, it suggests you might also carry genetic variants linked to these conditions. Understanding this can help you focus on lifestyle choices to mitigate those risks.

4. Why do I gain weight around my stomach, not my hips?

Your genetics strongly influence where your body stores fat. Some individuals are genetically predisposed to accumulate more visceral fat around their abdomen, while others tend to store it subcutaneously in other areas. This pattern is linked to an increased risk for metabolic disorders and cardiovascular disease.

5. Can exercise really overcome bad family history?

While genetics play a significant role in body shape and health risks, lifestyle factors like diet and physical activity are powerful influences. Regular exercise and healthy eating can positively modify your body composition and mitigate genetic predispositions. This proactive approach can significantly impact your health outcomes, even with a challenging family history.

6. Is it true that metabolism slows down as you age?

Yes, body shape and metabolism are dynamic traits that change throughout your lifespan. Genetic predispositions interact with age-related physiological changes, influencing how your body uses energy and stores fat. This means that maintaining a healthy body shape often requires adjusting your lifestyle as you get older.

7. Why do some people never gain weight no matter what they eat?

This often comes down to individual genetic differences that influence metabolism and appetite regulation. Some people have genetic variants that lead to higher energy expenditure or different fat storage mechanisms. Genes like TRAP1, involved in mitochondrial health and energy metabolism, can contribute to these varying body compositions.

8. I’m Hispanic - does my background affect my weight risk?

Yes, ancestry can influence genetic predispositions for body shape and weight-related traits. Different populations have unique genetic architectures, meaning certain genetic variants associated with BMI or fat distribution may be more common or have different effects in specific ethnic groups. Researchers use methods to account for these population differences to understand risk.

9. Why do weight loss diets work for others but not me?

Your individual genetic makeup significantly influences how your body responds to different diets and weight loss strategies. Genetic variants affect metabolism, appetite, and how your body processes nutrients. This means a diet effective for one person might not be optimal for you due to these underlying genetic differences.

10. Is a DNA test actually worth it for weight problems?

DNA tests can provide insights into your genetic predispositions for certain body shapes or metabolic traits. While they won’t tell you exactly what to do, understanding your genetic tendencies can help you personalize lifestyle choices. However, these tests represent only a part of the picture, as environmental factors also play a crucial role.

---

This FAQ was automatically generated based on current genetic research and may be updated as new information becomes available.

Disclaimer: This information is for educational purposes only and should not be used as a substitute for professional medical advice. Always consult with a healthcare provider for personalized medical guidance.

References

[1] Fox, C., and J. Dupuis. “Genetic analysis of adiposity traits in the Framingham Heart Study.” BMC Medical Genetics, vol. 8, suppl. 1, 2007, p. S18.

[2] The International HapMap Consortium. “A second generation human haplotype map of over 3.1 million SNPs.” Nature, vol. 449, 2007, pp. 851–861.

[3] Devlin, B., and K. Roeder. “Genomic control for association studies.” Biometrics, vol. 55, 1999, pp. 997–1004.

[4] Lawlor, D. A., et al. “Geographical variation in cardiovascular disease, risk factors, and their control in older women: British Women’s Heart and Health Study.”J Epidemiol Community Health, vol. 57, 2003, pp. 134–140.

[5] Campbell, Christopher D., et al. “Demonstrating stratification in a European American population.” Nature Genetics, vol. 37, 2005, pp. 868–872.

[6] Gunnell, D., et al. “Height, leg length, and cancer risk: A systematic review.”Epidemiologic Reviews, vol. 23, 2001, pp. 313–342.

[7] Hill, J. O., and J. C. Peters. “Environmental contributions to the obesity epidemic.”Science, vol. 280, 1998, pp. 1371–1374.

[8] Segal, N. L., and D. B. Allison. “Twins and virtual twins: Bases of relative body weight revisited.” Int J Obes Relat Metab Disord, vol. 26, 2002, pp. 437–441.

[9] Maurovich-Horvat, P., et al. “Comparison of anthropometric, area- and volume-based assessment of abdominal subcutaneous and visceral adipose tissue volumes using multi-detector computed tomography.” Int J Obes (Lond), 2006.

[10] Comuzzie, A. G., et al. “Searching for genes underlying normal variation in human adiposity.” J Mol Med, vol. 79, 2001, pp. 57-70.

[11] Rankinen, T., et al. “The human obesity gene map: the 2005 update.”Obesity (Silver Spring), vol. 14, 2006, pp. 529-644.

[12] Atwood, L. D., et al. “Genomewide Linkage Analysis of Body Mass Index across 28 Years of the Framingham Heart Study.” Am J Hum Genet, vol. 71, 2002, pp. 1044-1050.

[13] Fox, C. S., et al. “Genome-Wide Linkage to Chromosome 6 for Waist Circumference in the Framingham Heart Study.” Diabetes, vol. 53, 2004, pp. 1399-1402.

[14] Cupples, L. A., et al. “The Framingham Heart Study 100K SNP genome-wide association study resource: Overview of 17 phenotype working group reports.” BMC Med Genet, vol. 8, no. Suppl 1, 2007, p. S1.

[15] Collins, F. S. “Positional cloning: Let’s not call it reverse anymore.” Nat Genet, vol. 1, 1992, pp. 3–6.

[16] Botstein, D., and N. Risch. “Discovering genotypes underlying human phenotypes: Past successes for Mendelian disease, future approaches for complex disease.”Nat Genet, vol. 33, no. Suppl, 2003, pp. 228–237.

[17] Hirschhorn, J. N., and M. J. Daly. “Genome-wide association studies for common diseases and complex traits.” Nat Rev Genet, vol. 6, 2005, pp. 95–108.

[18] Wang, W. Y., et al. “Genome-wide association studies: Theoretical and practical concerns.” Nat Rev Genet, vol. 6, 2005.

[19] Calle, E. E., et al. “Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.”N Engl J Med, vol. 348, 2003, pp. 1625-1638.

[20] American Heart Association. 2003 Heart and Stroke Statistical Update. Dallas, Texas, 2002.

[21] Hubert, Helen B., et al. “Obesity as an Independent Risk Factor for Cardiovascular Disease: A 26-Year Follow-up of Participants in the Framingham Heart Study.”Circulation, vol. 67, 1983, pp. 968-977.

[22] Fehily, A. M., Butland, B. K., & Yarnell, J. W. “Body fatness and frame size: the Caerphilly study.” Eur J Clin Nutr, vol. 44, 1990, pp. 107–111.

[23] The Caerphilly and Speedwell Collaborative Group. “Caerphilly and Speedwell collaborative heart disease studies.”J Epidemiol Community Health, vol. 38, 1984, pp. 259–262.

[24] Paediatr. Perinat. Epidemiol. “ALSPAC-the Avon Longitudinal Study of Parents and Children. I: study methodology.” Paediatr. Perinat. Epidemiol., vol. 15, 2001, pp. 74–87.

[25] Rogers, I. S., et al. “Associations of size at birth and dual-energy X-ray absorptiometry measures of lean and fat mass at 9 to 10 y of age.” Am. J. Clin. Nutr., vol. 84, 2006, pp. 739–747.

[26] Leary, S. D., et al. “Smoking during pregnancy and offspring fat and lean mass in childhood.” Obesity (Silver Spring), vol. 14, 2006, pp. 2284–2293.

[27] Knight, B., et al. “The Exeter Family Study of Childhood Health (EFSOCH): study protocol and methodology.” Paediatr. Perinat. Epidemiol., vol. 20, 2006, pp. 172–179.

[28] Vartiainen, E., et al. “Cardiovascular risk factor changes in Finland, 1972–1997.” Int. J. Epidemiol., vol. 29, 2000, pp. 49–56.

[29] ARIC Investigators. “The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives.”Am J Epidemiol, vol. 129, 1989, pp. 687–702.

[30] Hsueh, W. C., et al. “Diabetes in the Old Order Amish: characterization and heritability analysis of the Amish Family Diabetes Study.” Diabetes Care, vol. 23, 2000, pp. 595–601.

[31] Streeten, E. A., et al. “Reduced incidence of hip fracture in the Old Order Amish.”J Bone Miner Res, vol. 19, 2004, pp. 308–313.